The Therapeutic Goods Administration (TGA) approved submissions from the Australian Red Cross Lifeblood (Lifeblood) to remove the deferral period for donors who
We developed the Criteria for the clinical use of immunoglobulin in Australia (the Criteria) using specialist working groups of expert clinicians to identify th
In December 2020, the National Blood Authority (NBA) finalised a procurement process for new national contracts for the supply of imported immunoglobulin (Ig) p